71238741

Capping Illusions: Why limits on out-of-pocket drug spend don’t work.

While a proposed cap on out-of-pocket drug spend seems to be the common response to the current drug pricing conundrum, in reality there are significant  drawbacks. On the surface, capping out of pocket drug costs seems like a great idea.  Patients would no longer have to worry about paying exorbitant prices for their medications. However, it is important to think about …

12669067945_e017b825c8_z

The High Price of Specialty Drugs: The Self-Insured burden and a cause for concern for HR managers

A new CVS Caremark report projects that specialty drug spend is expected to quadruple in 2020, reaching approximately $418 billion a year. Currently, specialty drug spend accounts for 30% of the total drug spend and by 2018, it will account for half of a companies drug spend. This article will discuss current challenges faced by self-insured companies when it comes …